"Chairman & Chief Executive Officer Founder of AUM Biosciencesand Chairman of AUM’s Board of Directors. Extensive experience in structuring and managing global deals worth over US$5 billion in drug development with major pharmaceuticals, and biotech companies. Previously held senior business development and management roles at IQVIA, EPS International and ICON and many more reputed global enterprises Achieved 145M USD PE deal with a major pharmaceutical company that resulted in achieving POC for 3 major oncology drugs currently on the market with peak sales of over 4B USD combined along with other founders Key Opinion Leader to Korean Health Industry Development Institute Master’s Degree in Pharmaceutical Sciences from Kingston University with research focus in Aromatase inhibitors in Breast cancer. Bachelor of Pharmacy from University of Mumbai"